Production (Stage)
Kronos Bio, Inc.
KRON
$0.872
$0.00210.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.19M | 9.85M | 9.86M | 8.41M | 7.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.19M | 9.85M | 9.86M | 8.41M | 7.59M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 9.19M | 9.85M | 9.86M | 8.41M | 7.59M |
| SG&A Expenses | 25.41M | 27.68M | 32.14M | 35.89M | 39.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.79M | 73.28M | 87.86M | 104.52M | 115.50M |
| Operating Income | -50.60M | -63.43M | -78.00M | -96.11M | -107.92M |
| Income Before Tax | -64.49M | -86.08M | -85.59M | -102.85M | -116.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.49 | -86.08 | -85.59 | -102.85 | -116.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.49M | -86.08M | -85.59M | -102.85M | -116.39M |
| EBIT | -50.60M | -63.43M | -78.00M | -96.11M | -107.92M |
| EBITDA | -49.14M | -61.72M | -76.22M | -94.23M | -105.87M |
| EPS Basic | -1.07 | -1.43 | -1.44 | -1.75 | -2.00 |
| Normalized Basic EPS | -0.46 | -0.59 | -0.74 | -0.93 | -1.06 |
| EPS Diluted | -1.07 | -1.43 | -1.44 | -1.75 | -2.00 |
| Normalized Diluted EPS | -0.46 | -0.59 | -0.74 | -0.93 | -1.06 |
| Average Basic Shares Outstanding | 241.56M | 240.28M | 238.20M | 236.04M | 233.33M |
| Average Diluted Shares Outstanding | 241.56M | 240.28M | 238.20M | 236.04M | 233.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |